References
- Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer. 2015 Mar 3;112:943–947.
- Cancer Research UK. Cancer statistics for the UK. [cited 2017 Dec 1]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk#heading-Two
- Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer. 2012;107:1195–1202.
- Basch E. Toward patient-centered drug development in oncology. New England J Med. 2013 July 3. DOI:10.1056/NEJMp1114649.
- Corner J, Wright D, Hopkinson J, et al. The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer. 2007;96:875–881.
- Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.
- Foster C, Haviland J, Winter J, et al. Pre-surgery depression and confidence to manage problems predict recovery trajectories of health and wellbeing in the first two years following colorectal cancer: results from the CREW cohort study. PLoS One. 2016;11:e0155434.
- Macmillan Cancer Support. Throwing light on the consequences of cancer and its treatment. 2013 [cited 2017 Dec 1]. Available from: https://www.macmillan.org.uk/documents/aboutus/research/researchandevaluationreports/throwinglightontheconsequencesofcanceranditstreatment.pdf
- Dawson J, Doll H, Fitzpatrick R, et al. The routine use of patient reported outcome measures in healthcare settings. Bmj. 2010;340:c186.
- Howell D, Molloy S, Wilkinson K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Annals of Oncology. 2015;26:1846–1858.
- Klag MJ, MacKenzie EJ, Carswell CI, et al. Foreword: the role of the patient in promoting patient-centered outcomes research. Patient. 2008;1:1–3.
- Osaba D. Translating the science of patient-reported outcomes assessment into clinical practice. JNCI Monogr. 2007;37:5–11.
- Rabin R, Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001 Jul;33:337–343.
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67:361–370.
- Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376.
- Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–579.
- Food and Drug Administration. Guidance for industry – patient-reported outcome measures: use in medical product development to support labeling claims. 2009 [cited 2017 Dec 1]. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf
- Basch E, Jia C, Heller G, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101:1624–1632.
- Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. Bmj. 2001;322:1297–1300.
- NICE. Guidance on the use of trastuzumab for the treatment of advanced breast cancer. National Institute for health and care excellence. Technology appraisal guidance [TA34]. [cited 2017 Oct 6]. Available from: https://www.nice.org.uk/guidance/ta34
- EMA. Reflection paper on the use of patient reported outcome (PRO) measures in oncology studies (Draft). European Medicines Agency 2014; Oncology Working Party; Doc. ref. EMA/CHMP/292464/2014
- Moorcraft SY, Marriot C, Peckitt C, et al. Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials. 2016;17:17.
- Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Annals of Oncology. 2000;11:939–945.
- Chalmers I, Bracken MB, Djulbegovic B, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–165.
- Kyte D, Ives J, Draper H, et al. Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists. PLOS One. 2013;8:10.
- Kyte D, Duffy H, Fletcher B, et al. Systematic evaluation of the Patient-Reported Outcome (PRO) content of clinical trial protocols. PLoS ONE. 2014;9:e110229.
- Ahmed K, Kyte D, Keeley T, et al. Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol. BMJ Open. 2016;6:e012863.
- Kyte D, Retzer A, Ahmed K, et al. Systematic evaluation of Patient-Reported Outcome (PRO) protocol content and reporting in cancer clinical trials: the EPiC study, philadephlia USA, 2017 Oct 18 [cited 2018 Feb 28]. Available from: http://www.isoqol.org/UserFiles/AC17/AC17-FP_web.pdf
- Mercieca-Bebber R, Friedlander M, Kok PS, et al. The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols. Qual Life Res. 2016;25:2457–2465.
- Brundage M, Bass B, Davidson J, et al. Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers. Qual Life Res. 2011;20:653–664.
- Schandelmaier S, Conen K, Von Elm E, et al. Planning and reporting of quality-of-life outcomes in cancer trials. Ann Oncol. 2015;26:1966–1973.
- Efficace F, Fayers P, Pusic A, et al.; On behalf of EORTC Quality of Life Group. Promotion registry. Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT PRO extension: a pooled analysis of 557 Trials. Cancer. 2015;121:3335–3342.
- Tabak RG, Siqueira Reis R, Wilson P, et al. Dissemination of health-related research among scientists in three countries: access to resources and current practices. Biomed Res Int. 2015.
- McGowan J. Measuring most informative titles (declarative titles) as a knowledge translation dissemination tool is possible using altmetrics. J Clin Epidemiol. 2017;85:12–13.
- Cruz Rivera S, Kyte DG, Aiyegbusi OL, et al. Assessing the impact of healthcare research: A systematic review of methodological frameworks. PLoS Med. 2017;14:e1002370.
- Peters DH, Adam T, Alonge O, et al. Implementation research what it is and how to do it. Bmj. 2013;347:f6753.
- Neta G, Glasgow RE, Carpenter CR, et al. A framework for enhancing the value of research for dissemination and implementation. Am J Public Health. 2015;105:49–57.
- Colditz GA. The promise and challenges of dissemination and implementation research. In: Brownson RC, Colditz GA, Proctor EK, eds. Dissemination and implementation research in health: translating science to practice. 1st ed. New York: Oxford University Press; 2012. p. 3–23.
- Chan A, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. Bmj. 2013;346:e7586.
- Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO Extension. Jama. 2018;319:483–494.
- EU. Regulation (EU) No 536/2014 of the European parliament and of the council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing directive 2001/20/EC. 2014 [cited 2017 Nov 01]. Available from: http://www.hra.nhs.uk/resources/before-you-apply/types-of-study/clinical-trials-of-investigational-medicinal-products/clinical-trials-investigational-medicinal-products-ctimps-eu-legislation/
- Calvert M, Blazeby J, Altman DG, et al. Reporting of patient reported outcomes in randomised trials: the CONSORT PRO extension. Jama. 2013;309:814–822.
- House of Lords Select Committee. Barrier to trade and security if data transfers are hindered after Brexit. 2017 [cited 2017 Nov 01]. Available from: https://www.parliament.uk/business/committees/committees-a-z/lords-select/eu-home-affairs-subcommittee/news-parliament-2017/data-protection-report-published/
- Impact of Brexit on cancer care and research. Lancet Oncol. 2016;17:539.
- Eurodis. Rare disease patient registries. 2013 [cited 2017 Nov 01]. Available from: https://www.eurordis.org/sites/default/files/publications/Factsheet_registries.pdf
- Cancer Research UK. Cancer survival statistics. 2017 [cited 2017 Nov 01]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/survival
- Fallowfield L, Nadler E, Gilloteau I, et al. Quality of survival: a new concept framework to assess the quality of prolonged life in cancer. Expert Rev Quality Life Cancer Care. 2017;2.
- Kotronoulas G, Kearney N, Maguire R, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32:1480–1501.
- Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient wellbeing: a randomized controlled trial. J Clin Oncol. 2004;22:714–724.
- Gotay CC, Kawamoto CT, Bottomley A, et al. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008;26:1355–1363.
- Efficace F, Bottomley A, Coens C, et al. Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer. 2006;42:42–49.
- Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Jama. 2017;318:197–198.
- Sutherland HJ, Llewellyn-Thomas HA, Lockwood GA, et al. Cancer patients: their desire for information and participation in treatment decisions. J Royal Soc Med. 1989;82:260–263.
- Cassileth BR, Zupkis RV, Sutton-Smith K, et al. Information and participation preferences among cancer patients. Ann Intern Med. 1980;92:832–836.
- Brundage M, Leis A, Bezjak A, et al. Cancer patients’ preferences for communicating clinical trial quality of life information: a qualitative study. Qual Life Res. 2003;12:395–404.
- Davison J, Degner LF, Morgan TR. Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum. 1995;22:1401–1408.
- Feldman-Stewart D, Brundage MD, Hayter C, et al. What questions do patients with curable prostate cancer want answered? Med Decision Making. 2000;20:7–19.
- Søreide K, Søreide AH. Using patient-reported outcome measures for improved decision-making in patients with gastrointestinal cancer – the last clinical frontier in surgical oncology? Front Oncol. 2013;3:157.
- Charles L, Bardes MD. Defining “Patient-Centered Medicine”. N Engl J Med. 2012;366:782–783.
- Srivastava R. Dealing with uncertainty in a time of plenty. N Engl J Med. 2011;365:2252–2253.
- Detmar SB, Muller MJ, Schornagel JH, et al. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. Jama. 2002;288:3027–3034.
- Baeksted C, Pappot H, Nissen A, et al. Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients. J Patient-Reported Outcomes. 2017;1:1.
- Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Jama. 2017;318:197–198.
- Holch P, Warrington L, Bamforth LCA, et al. Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment. Annals of Oncology. 2017;28:2305–2311.
- Cancer Research UK. Taskforce report: achieving world-class cancer outcomes. 2015 [cited 2017 Nov 02]. Available from: http://scienceblog.cancerresearchuk.org/2015/07/19/taskorce-report-achieving-world-class-cancer-outcomes/?utm_source=twitter_cr_uk&utm_medium=cruksocialmedia&utm_campaign=owntwitter_tweet/
- NHS England. New quality of life measure for recovering cancer patients. 2017 [cited 2017 Nov 02]. Available from: https://www.england.nhs.uk/2017/09/new-quality-of-life-measure-for-recovering-cancer-patients/
- Quality Health. National cancer patient experience survey: 2015 reports. [cited 2017 Dec 1]. Available from: http://www.ncpes.co.uk/index.php/reports/2015-reports
- Quality Health. National cancer patient experience survey 2016: national results summary. [cited 2017 Oct 6]. Available from: http://www.ncpes.co.uk/index.php/reports/2016-reports/national-reports-1/3572-cpes-2016-national-report/file.
- NHS England. Achieving world-class cancer outcomes: taking the strategy forward. 2016. [cited 2017 Oct 6]. Available from: https://www.england.nhs.uk/wp-content/uploads/2016/05/cancer-strategy.pdf
- NHS England. Implementing the cancer taskforce recommendations: commissioning person centred care for people affected by cancer. 2016 [cited 2017 Oct 6]. Available from: https://www.england.nhs.uk/wp-content/uploads/2016/04/cancer-guid-v1.pdf
- Independent Cancer Taskforce. Achieving world-class cancer outcomes: a strategy for England 2015-2020. 2015 [cited 2017 Oct 6]. Available from: http://www.cancerresearchuk.org/sites/default/files/achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020.pdf.
- Basch E. The rise of patient-reported outcomes in oncology. ASCO Daily News. [cited 2017 Nov 27]. Available from: https://am.asco.org/daily-news/rise-patient-reported-outcomes-oncology
- Sellers L, Savas AN, Davdas R, et al. Patient-reported outcome measures in metastatic prostate cancer. Trends Urology Men’s Health. 2016;7:28–32.
- Bouazza YB, Chiari I, El Kharbouchi O, et al. Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review. Lung Cancer. 2017;113:140–151.
- Rogers SN. Improving quality-of- life questionnaires in head and neck cancer. Expert Rev Quality Life Cancer Care. 2016;61–71. DOI:10.1080/23809000.2016.1142357
- Rogers SN, Barber B. Using PROMs to guide patients and practitioners through the head and neck cancer journey. Patient Relat Outcome Meas. 2017;8:133–142.
- Weldring T, Smith S. Article commentary: patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Services Insights. 2013;6:61–68.
- Catt S, Starkings R, Shilling V, et al. Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review. J Cancer Surviv. 2017;11:211–232.
- Howell D, Molloy S, Wilkinson K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Annals of Oncology. 2015;26:1846–1858.
- Kirwan JR, Minnock P, Adebajo A, et al. Patient perspective: fatigue as a recommended patient-centred outcome measure in rheumatoid arthritis. J Rheumatol. 2007;34:1174–1177.
- Tugwell P, Bombardier C. A methodologic framework for developing and selecting endpoints in clinical trials. J Rheumatol. 1982;9:758–762.
- Streiner D, Norman G. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 1989.
- Bell MJ, Bombardier C, Tugwell P. Measurement of functional status, quality of life, and utility in rheumatoid arthritis. Arthritis Rheum. 1990;33:591–601.
- Antunes B, Harding R, Higginson IJ. Implementing patient-reported outcome measures in palliative care clinical practice: A systematic review of facilitators and barriers. Palliative Medicine. 2014;28:158–175.
- Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value in Health. 2005;8:94–104.
- Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity - Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2 - Assessing respondent understanding. Value in Health. 2011;14:978–988.
- Reeve BB, Wyrwich KW, Wu AW, et al. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013;22:1889–1905.
- Schultz KF, Altman DG, Moher D, et al. CONSORT 2010 Statement: updated Guidelines For Reporting Parallel Group Randomized trials. Ann Intern Med. 2010;152:726–732.
- Maher J, Velikova G, Betteley A. Incurable, but treatable: how to address challenges for an emerging group. BMJ Support Palliat Care. 2015;5:322–324.
- Foster C, Calman L, Richardson A, et al. Improving the lives of people living with and beyond cancer: generating the evidence needed to inform policy and practice. J Cancer Policy. 2018. DOI:10.1016/j.jcpo.2018.02.004.
- Evans SM, Millar JL, Moore CM, et al. Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes. BMJ Open. 2017;7:e017006.